文献速递骨软组织肉瘤与黑色素瘤

儿童癌症成年幸存者中的黑色素瘤:儿童癌症幸存者研究报告

Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.
PubMed 文献 · J Clin Oncol · 2025-01-08

该研究评估儿童癌症幸存者队列中黑色素瘤的发病率、危险因素和结局;40年黑色素瘤累积发病率为1.1%,侵袭性皮肤或眼部黑色素瘤的标准化发病比为2.0,侵袭性黑色素瘤与死亡风险增加相关。

要点

  • 儿童癌症幸存者40年黑色素瘤累积发病率为1.1%(95%CI 0.9-1.4)。
  • 侵袭性皮肤或眼部黑色素瘤的标准化发病比为2.0(95%CI 1.6-2.4)。
  • 对应身体区域累积辐射剂量≥40 Gy、环磷酰胺等效剂量≥20,000 mg/m2和博来霉素暴露与皮肤黑色素瘤风险增加相关。

核心结论

  • 儿童癌症幸存者黑色素瘤风险较一般人群增加两倍以上,侵袭性黑色素瘤患者死亡风险增加两倍以上。
  • 高剂量辐射、烷化剂暴露和博来霉素是黑色素瘤的重要危险因素,应考虑在未来患者指导和筛查中纳入。

研究设计与样本

  • 儿童癌症幸存者研究队列分析,纳入25,716名参与者,计算累积发病率和标准化发病比,采用多变量Cox模型确定黑色素瘤危险因素的风险比(HR)及95%CI。
  • 将七个身体区域的辐射暴露和每个幸存者八个区域中每个区域的黑色素瘤状态整合入Cox模型。

主要发现

  • 在25,716名参与者中,160名幸存者发生177例黑色素瘤(110例侵袭性、62例原位皮肤、5例眼部)。
  • 所有参与者40年黑色素瘤累积发病率为1.1%(95%CI 0.9-1.4),接受累积辐射剂量≥40 Gy者中为1.5%(95%CI 1.0-2.1)。
  • 与一般人群相比,侵袭性皮肤或眼部黑色素瘤的标准化发病比为2.0(95%CI 1.6-2.4)。
  • 对应身体区域累积辐射剂量≥40 Gy(HR 2.0,95%CI 1.1-3.7)、环磷酰胺等效剂量≥20,000 mg/m2(HR 1.9,95%CI 1.1-3.6)和博来霉素暴露(HR 2.2,95%CI 1.2-4.1)与皮肤黑色素瘤风险增加相关。
  • 任何部位的侵袭性黑色素瘤与死亡风险增加相关(HR 2.4,95%CI 1.7-3.3)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Melanoma as a subsequent malignant neoplasm has been described among childhood cancer survivors; however, the risk factors and long-term survival are not well understood. METHODS: We assessed incidence, risk factors, and outcomes for melanoma among participants in the Childhood Cancer Survivor Study cohort. Cumulative incidence and standardized incidence ratios (SIRs) were calculated, and multivariable Cox models were used to determine hazard ratios (HRs) and associated 95% CI for melanoma risk factors. Radiation exposure to seven body regions and melanoma status for each of eight regions per survivor were integrated into the Cox model. RESULTS: Among 25,716 participants, 177 melanomas developed in 160 survivors (110 invasive, 62 in situ cutaneous, five ocular). The 40-year melanoma cumulative incidence was 1.1% (95% CI, 0.9 to 1.4) for all participants and 1.5% (95% CI, 1.0 to 2.1) among those receiving a cumulative radiation dose of ≥40 Gy. Compared with the general population, the SIR for invasive skin or ocular melanoma was 2.0 (95% CI, 1.6 to 2.4). A cumulative radiation dose of ≥40 Gy to the corresponding body region(s) of the melanoma (HR, 2.0 [95% CI, 1.1 to 3.7]), a cumulative cyclophosphamide equivalent dose of ≥20,000 mg/m2 (HR, 1.9 [95% CI, 1.1 to 3.6]), and bleomycin exposure (HR, 2.2 [95% CI, 1.2 to 4.1]) were associated with increased cutaneous melanoma. Invasive melanoma at any site was associated with an increased risk of death (HR, 2.4 [95% CI, 1.7 to 3.3]). CONCLUSION: Childhood cancer survivors have more than a two-fold increased risk of melanoma compared with the general population, and those with an invasive melanoma have more than a two-fold risk of death. High-dose radiation and alkylating agent exposure, and bleomycin are important risk factors for melanoma and should be considered in future patient guidance and screening.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Rotz SJ, Stratton K, Leisenring WM, et al. Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2025. PMID: 39778123. doi:10.1200/JCO-24-01519

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。